AESKULISA TTG A AND AESKULISA TTG G— 510(k) K042644

Substantially Equivalent

Aesku, Inc.

FDA 510(k) clearance K042644 for AESKULISA TTG A AND AESKULISA TTG G, Substantially Equivalent on 2005-06-01. Applicant: Aesku, Inc..

Clearance details

Applicant: Aesku, Inc.
Product code: Code MVM
Advisory panel: Immunology
Date received: 2004-09-27
Decision date: 2005-06-01
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Miami, FL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.